Courtney Cook, BSN, RN; Jessica Mansour, BSN, RN; Joanne Nassar, BSN, RN; Brooke Nayak, BSN, RN

All articles by Courtney Cook, BSN, RN; Jessica Mansour, BSN, RN; Joanne Nassar, BSN, RN; Brooke Nayak, BSN, RN

GVHD in pediatric HSCT patients: Clinical trials for Rituximab

GVHD in pediatric HSCT patients: Clinical trials for Rituximab

By

Courtney Cook, BSN, RN; Jessica Mansour, BSN, RN; Joanne Nassar, BSN, RN; Brooke Nayak, BSN, RN

August 15, 2012

The CD20 antagonist is a potentially effective preventive and treatment for this common adverse effect of hematopoietic stem cell transplantation.

Next post in CE Courses

IBC diagnosis is still based on visible symptoms rather than a specific pathological test.

Inflammatory breast cancer: An atypical breast cancer type